Atul Khire, PhD
About Atul Khire, PhD
Atul Khire, PhD, is a Principal Scientist and Analytical Team Lead at Bristol Myers Squibb in the New York City Metropolitan Area, with extensive experience in immunoassays and cell-based assays.
Current Role at Bristol Myers Squibb
Atul Khire, PhD, serves as the Principal Scientist and Analytical Team Lead at Bristol Myers Squibb in the New York City Metropolitan Area. His expertise spans various advanced analytical techniques and regulatory compliance. He is responsible for leading the analytical team, developing assays, and setting up analytical development labs in compliance with stringent USFDA CFR part 11 and 21 regulations. His outstanding contributions were recognized with the 'RNA Award' for his work in lab setup and assay development.
Previous Experience at PTC Therapeutics
Atul Khire worked at PTC Therapeutics, Inc. in the New York City Metropolitan Area, initially as a Scientist I from 2019 to 2021, and subsequently as a Scientist II from 2021 to 2022. Over three years, he honed his skills in immunoassays and cell-based assays, contributing significantly to the company's analytics and research initiatives.
Research Fellowship at Memorial Sloan Kettering Cancer Center
Prior to his industry roles, Atul Khire served as a Postdoctoral Research Fellow at Memorial Sloan Kettering Cancer Center from 2018 to 2019. Located in the Greater New York City Area, this position allowed him to delve into cancer research, focusing on the application and development of advanced analytical techniques in biological sciences.
Education and Research Background
Atul Khire completed his PhD in Biological Sciences at The University of Toledo between 2012 and 2017. His educational background also includes a Master's degree in Microbiology from Bangalore University (2006-2008) and a Bachelor's degree in Microbiology from Savitribai Phule Pune University (2003-2006). His extensive academic journey laid the foundation for his expertise in various complex assays and analytical methodologies.
Expertise in Analytical Assays and Regulatory Filings
Atul Khire is proficient in numerous analytical techniques including NanoString-based gene expression assays, MSD-based ELISA assays, TCID50, qPCR, and western blot. He has successfully set up automated assays utilizing advanced machinery such as Cytation 5, BioSpa, and Qiagility. He supports analytical assay development for IND & BLA/MAA filings adhering to guidelines from FDA, EMA, ICH, and WHO. His experience also includes collaborating with Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs).